Short-Term Debt to Capital: OraSure Technologies, Inc. (OSUR)

OraSure Technologies (OSUR) develops advanced rapid infection diagnostic methods, as evidenced by this price chart where the indicator stands at 0.00. Top management's strategy relies on the popularization of at-home tests and the modernization of sampling tools. The business is currently fighting for market share by expanding its product range to avoid losses from cheap imported alternatives following the decline in pandemic-driven demand.

OraSure Technologies (OSUR) is scaling the production of diagnostic tests, leveraging high loyalty within the medical community. This metric compares obligations with a maturity of more than one year to total equity, reflecting the business's dependence on external financing. It measures financial autonomy, where a sharp increase indicates a risk of losing stability. By analyzing the share of short-term loans in equity, an investor can assess the company's real debt load.